Several Actionable Targets Identified in Testicular Cancer
This video highlights recent research in cisplatin-resistant testicular cancer, including a study on whole exome sequencing that revealed several actionable targets.
In this video, Aditya Bagrodia, MD, of the University of Texas Southwestern Medical Center, discusses recent research in germ cell tumors.
A recent study that used whole exome sequencing in platinum-resistant disease revealed that many of these patients have actionable targets.
Bagrodia, who gave a presentation on this topic at the 2017 Genitourinary Cancers Symposium in Orlando, Florida, also looks ahead toward trials examining the potential of different immunotherapies in this setting.
Related Videos
Related Content
